Announcements Trials
Browse Landscape

Phase

Phase 2 22Phase 3 11Phase 1 10Phase NA 4Phase 1/2 4Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 4Genitourinary 3Other hematologic neoplasm 2Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Neuroblastoma 3Glioblastoma 1

Interventions

Temozolomide 102Radiotherapy 47Bevacizumab 33Carboplatin 23Irinotecan 20pembrolizumab 17Radiosurgery 16Nivolumab 16Radiation 14Cyclophosphamide 11Magnetic Resonance Spectroscopy 10fludarabine 8Trastuzumab 8Radiotherapy, Intensity-Modulated 8Carmustine 8Surgical Procedures, Operative 7Specimen Handling 7Pemetrexed 7Paclitaxel 7Interleukin-2 7Filgrastim 7Everolimus 7Erlotinib Hydrochloride 7temsirolimus 6Vorinostat 6Radiotherapy, Conformal 6Lomustine 6Ipilimumab 6Granulocyte-Macrophage Colony-Stimulating Factor 6Gemcitabine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Isotretinoin × CNS × Clear all
NCT00555399 2024-08-22

Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)

M.D. Anderson Cancer Center

Phase 1/2 Terminated
55 enrolled 19 charts
CNS

Glioblastoma

NCT03291080 2021-10-19

My-CRA

Nova Laboratories Limited

Phase 1/2 Completed
20 enrolled 15 charts
CNS

Neuroblastoma

NCT01701479 2020-07-14

LTI

St. Anna Kinderkrebsforschung

Phase 1/2 Unknown
288 enrolled
CNS

Neuroblastoma

NCT01592045 2015-09-23

ch14.18 Pharmacokinetic Study in High-risk Neuroblastoma

United Therapeutics

Phase 1/2 Completed
28 enrolled 11 charts
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡